Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 4 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 12102617

    Antimicrobial compositions containing a synergistic combination of activated creatinine and an imidazole antifungal agent

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 1, 2024 · Expires Sep 26, 2044

    granted
  2. US 12084468

    Synthesis of backbone modified morpholino oligonucleotides and chimeras using phosphoramidite chemistry

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  3. US 12083230

    Nano-encapsulation using GRAS materials and applications thereof

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  4. US 12083137

    Triazole bisphosphonate geranylgeranyl diphosphate synthase inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 10, 2024 · Expires Sep 5, 2044

    granted
  5. US 12071436

    Anti-parasitic compounds and uses thereof

    The Regents of the University of California · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  6. US 12070472

    Treatment of drug resistant proliferative diseases with telomerase mediated telomere altering compounds

    The Board of Regents of the University of Texas System · Granted Aug 27, 2024 · Expires Aug 22, 2044

    granted
  7. US 12064514

    Ultrasound-sensitive peptide particles for spatially resolved molecule delivery

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Aug 20, 2024 · Expires Aug 15, 2044

    granted
  8. US 12042487

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 23, 2024 · Expires Jul 18, 2044

    granted
  9. US 12023348

    EGR1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Jul 2, 2024 · Expires Jun 27, 2044

    granted
  10. US 12011450

    Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  11. US 12011619

    Low intensity focused ultrasound for treating cancer and metastasis

    Montefiore Medical Center · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted
  12. US 12006363

    Anti-tetraspanin 33 agents and compositions and methods for making and using the same

    BioLegend, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  13. US 11999753

    Tetrahydropyridopyrimidine pan-KRas inhibitors

    Mirati Therapeutics, Inc. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  14. US 11992480

    Method for reducing side effects from administration of phosphodiesterase-4 inhibitors

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  15. US 11993569

    3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases

    Northwestern University · Granted May 28, 2024 · Expires May 23, 2044

    granted
  16. US 11963945

    Ozonides for treating or preventing virus infections

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  17. US 11964989

    KRas G12D inhibitors

    Mirati Therapeutics, Inc. · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  18. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    The Government of the United States · Granted Apr 23, 2024 · Expires Apr 18, 2044

    granted
  19. US 11952352

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  20. US 11951227

    Nanofiber structures and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted
  21. US 11944644

    T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Apr 2, 2024 · Expires Mar 28, 2044

    granted
  22. US 11932633

    KRas G12C inhibitors

    Mirati Therapeutics, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  23. US 11933866

    Magnetic resonance maps for analyzing brain tissue

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  24. US 11932871

    Methods of culturing t cells and uses of same

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted